未登录 分享 收藏
Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer GLP-1RA暴露与分化型甲状腺癌结构进展风险 Patrizio, Armando; Mauguen, Audrey; Fagin, James A.; Farooki, Azeez; Fish, Stephanie S.; Flory, James; Newman, Samantha; Presswala, Lubaina; Sabra, Mona M.; Tuttle, R. Michael; Boucai, Laura 分享 收藏
分享 收藏
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer alpelisib诱发晚期实体瘤和乳腺癌患者高血糖的风险分析 Rodon, Jordi; Demanse, David; Rugo, Hope S.; Burris, Howard A.; Simo, Rafael; Farooki, Azeez; Wellons, Melissa F.; Andre, Fabrice; Hu, Huilin; Vuina, Dragica; Quadt, Cornelia; Juric, Dejan 分享 收藏
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique 管理与alpelisib相关的高血糖和皮疹: 使用Delphi技术的专家共识建议 Gallagher, Emily J.; Moore, Heather; Lacouture, Mario E.; Dent, Susan F.; Farooki, Azeez; Goncalves, Marcus D.; Isaacs, Claudine; Johnston, Abigail; Juric, Dejan; Quandt, Zoe; Spring, Laura; Berman, Brian; Decker, Melanie; Hortobagyi, Gabriel N.; Kaffenberger, Benjamin H.; Kwong, Bernice Y.; Pluard, Timothy; Rao, Ruta; Schwartzberg, Lee; Broder, Michael S. 分享 收藏
分享 收藏
分享 收藏
A risk analysis of alpelisib (ALP)-induced hyperglycemia (HG) using baseline factors in patients (pts) with advanced solid tumours and breast cancer (BC): A pooled analysis of X2101 and SOLAR-1 Rodon, J.; Demanse, D.; Rugo, H. S.; Andre, F.; Janku, F.; Mayer, I.; Burris, H.; Simo, R.; Farooki, A.; Hu, H.; Lorenzo, I.; Quadt, C.; Juric, D. 分享 收藏
分享 收藏
EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation Sharma, P.; Farooki, A.; Fasching, P. A.; Loi, S.; Peterson, K.; Prat, A.; Tripathy, D.; Xu, B.; Yardley, D. A.; Mills, D.; Klauss, G.; Wong, C.; Andre, F. 分享 收藏
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer Diamond, Jennifer R.; Becerra, Carlos; Richards, Donald; Mita, Alain; Osborne, Cynthia; O'Shaughnessy, Joyce; Zhang, Chun; Henner, Randall; Kapoun, Ann M.; Xu, Lu; Stagg, Bob; Uttamsingh, Shailaja; Brachmann, Rainer K.; Farooki, Azeez; Mita, Monica 分享 收藏
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma McPherson, Victor; Reardon, Brendan; Bhayankara, Aravind; Scott, Sasinya N.; Boyd, Mariel E.; Garcia-Grossman, Ilana R.; Regazzi, Ashley M.; McCoy, Asia S.; Kim, Philip H.; Al-Ahmadie, Hikmat; Ostrovnaya, Irina; Roth, Andrew J.; Farooki, Azeez; Berger, Michael F.; Rosenberg, Jonathan E.; Solit, David B.; Van Allen, Eliezer; Milowsky, Matthew I.; Bajorin, Dean F.; Iyer, Gopa 分享 收藏
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE EXECUTIVE SUMMARY 美国临床内分泌医师协会/美国内分泌学会绝经后骨质疏松症诊断和治疗临床实践指南-2020更新执行摘要 Camacho, Pauline M.; Petak, Steven M.; Binkley, Neil; Diab, Dima L.; Eldeiry, Leslie S.; Farooki, Azeez; Harris, Steven T.; Hurley, Daniel L.; Kelly, Jennifer; Lewiecki, E. Michael; Pessah-Pollack, Rachel; McClung, Michael; Wimalawansa, Sunil J.; Watts, Nelson B. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score Mariotti, Veronica; Page, David B.; Davydov, Oksana; Hans, Didier; Hudis, Clifford A.; Patil, Sujata; Kunte, Siddharth; Girotra, Monica; Farooki, Azeez; Fornier, Monica N. 分享 收藏
Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Weekes, C.; Berlin, J.; Lenz, H-J.; O'Neil, B.; Messersmith, W.; Cohen, S.; Dendinger, C.; Shahda, S.; Kapoun, A.; Zhang, C.; Jenner, R.; Cattaruzza, F.; Xu, L.; Dupont, J.; Brachmann, R.; Uttamsingh, S.; Farooki, A.; Dotan, E. 分享 收藏
Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Messersmith, W.; Cohen, S.; Shahda, S.; Lenz, H-J.; Weekes, C.; Dotan, E.; Denlinger, C.; O'Neil, B.; Kapoun, A.; Zhang, C.; Henner, R.; Cattaruzza, F.; Xu, L.; Dupont, J.; Brachmann, R.; Uttamsingh, S.; Farooki, A.; Berlin, J. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏